Anmol Grover

Anmol Grover, Ph.D., currently serves as Director of Strategy and Portfolio Management at Amgen and Horizon, with previous experience as Associate Principal at Halloran Consulting Group, Inc., where strategic clinical development and life-cycle management were pivotal. Anmol Grover's consultancy roles, including a position at Putnam Associates, involved extensive product opportunity assessments in the life sciences sector, forecasting, and competitive landscape evaluations. Anmol Grover's academic background includes a Ph.D. from Carnegie Mellon University in Biochemistry, Biophysics, and Molecular Biology, coupled with earlier positions in virology and vaccine R&D. Research expertise encompasses innovative microscopy techniques for studying neuronal mechanisms and translation processes in eukaryotic cells.